NZ sharemarket starts week down 0.5%

NZ sharemarket starts week down 0.5%
(Image: Getty)
Graham Skellern
Cancer diagnostic company Pacific Edge slumped 55% after failing to get the backing for continued United States Medicare payments for its Cxbladder tests, and the New Zealand sharemarket joined global moves with a fall.After a sell-down on Wall Street at the weekend, the S&P/NZX 50 Index traded weakly till a late turnaround and closed at 12,827.33, down 68.65 points or 0.53%. Volumes were light, with 30.08 million shares worth $71.1 million changing hands – nearly half of them being Pacific Edge on trade of 13.12 million shares w...

More Markets

Weak dollar may impact February OCR cut
Markets

Weak dollar may impact February OCR cut

RBNZ expected to cut by another 50 basis points to 3.75% in Feb.

Building consents stabilising but no immediate recovery
Markets

Building consents stabilising but no immediate recovery

Housing consents rose 4.8% on year in November but fall 12% for 12-month period. 

Pacific Edge shares fall 63% after Novitas decision
Markets

Pacific Edge shares fall 63% after Novitas decision

Pacific Edge had $28.5m in reserves as at the end of December 2024. 

Beyond the glitter: Can gold hedge against a falling NZ dollar?
Markets

Beyond the glitter: Can gold hedge against a falling NZ dollar?

Gold gained 42% in NZ dollar terms last year, its value helped by falling interest rates.